The Clinical and Molecular Significance Associated with STING Signaling in Breast Cancer

Using a novel approach in estrogen receptor-positive (ER+) and negative breast cancer, researchers identified perinuclear-localized expression of STING in ER+ cases as an independent predictor of good prognosis, associated with immune cell infiltration and upregulation of immune checkpoints.